# Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis

> **NCT05282875** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 430 (estimated)

## Conditions studied

- Kidney Transplantation
- Immunosuppressive Agents
- HLA Sensitization
- Dialysis

## Interventions

- **DRUG:** management of immunosuppressive therapy

## Key facts

- **NCT ID:** NCT05282875
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-09-01
- **Target enrollment:** 430 (ESTIMATED)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282875, "Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05282875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*